## Abstract Epidemiological studies indicate that menopausal estrogenβprogestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A
β¦ LIBER β¦
Postmenopausal hormone therapy and breast cancer
β Scribed by Leon Speroff
- Book ID
- 111638018
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 168 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0969-711X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Postmenopausal hormone therapy and breas
β
Sulggi Lee; Laurence Kolonel; Lynne Wilkens; Peggy Wan; Brian Henderson; Malcolm
π
Article
π
2005
π
John Wiley and Sons
π
French
β 95 KB
π 2 views
Postmenopausal hormone therapy and breas
β
Peter Kenemans
π
Article
π
2005
π
Elsevier Science
π
English
β 150 KB
Postmenopausal hormone therapy before an
β
N.J. Bundred; L.E. Turner
π
Article
π
2004
π
Elsevier Science
π
English
β 110 KB
Obesity, hormone therapy, estrogen metab
β
Francesmary Modugno; Kevin E. Kip; Barbara Cochrane; Lewis Kuller; Thomas L. Klu
π
Article
π
2005
π
John Wiley and Sons
π
French
β 302 KB
π 2 views
## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HTβBMIβbreast cancer associations. We undertook a nested case
Postmenopausal hormone therapy and the r
β
Leon Speroff
π
Article
π
2004
π
Elsevier Science
π
English
β 68 KB
Postmenopausal hormone therapy and risk
β
Laura M. Newcomer; Polly A. Newcomb; John D. Potter; Yutaka Yasui; Amy Trentham-
π
Article
π
2003
π
Springer Netherlands
π
English
β 99 KB